NPS Pharmaceuticals Income Statement
- Quarterly: December 2012 - September 2010 Previous Quarters
- Annual
| Income | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 |
| Revenue | 27.18M | 27.02M | 53.52M | 22.92M | 26.26M | 24.60M | 27.21M | 23.58M | 24.04M | 21.05M |
| Cost of Goods Sold | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Fees | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Profit | 27.18M | 27.02M | 53.52M | 22.92M | 26.25M | 24.60M | 26.71M | 21.04M | 23.98M | 21.05M |
| Amortization Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Depreciation, Amortization, Depletion Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| R&D Expense | 24.04M | 17.96M | 32.64M | 20.20M | 21.56M | 20.23M | 17.14M | 14.90M | 16.14M | 19.36M |
| G&A Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| SG&A Expense | 11.16M | 8.329M | 9.670M | 7.770M | 7.198M | 6.413M | 5.539M | 5.076M | 5.051M | 5.410M |
| Total Operating Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non Operating Interest Income | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Non-Operating Int Exp | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Special Income and Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Income and Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pre-Tax Income | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Income from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Income | -12.20M | -3.324M | 7.355M | -10.56M | -8.636M | -12.35M | -6.132M | -9.150M | -6.397M | -15.69M |
| Basic EPS | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 |
| EPS Basic from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS Basic from Acc. Chg. | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS Basic | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Diluted EPS | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 |
| EPS Diluted from Cont. Ops | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS Diluted from Acc. Chg. | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS Diluted | -0.1398 | -0.0400 | 0.0800 | -0.1200 | -0.0994 | -0.1400 | -0.0700 | -0.1300 | -0.0945 | -0.2600 |
| Shares Data | 2012-12 | 2012-09 | 2012-06 | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 |
| Average Basic Shrs Outs | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Diluted Shrs Outs | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
